Investment
Features
FeesSafety
Academy
More
Pluang+

Atmus Filtration posts strong Q1 2026 growth but remains a Hold due to geopolitical and trade risks.

Company Fundamentals
04 Aug 2026
Seeking Alpha
View Source
Neutral
Atmus Filtration posts strong Q1 2026 growth but remains a Hold due to geopolitical and trade risks.

Atmus Filtration Technologies reported strong Q1 2026 results with revenue of $477.5M, net income of $48.4M, and EBITDA of $94.5M, boosted by the Koch Filter acquisition and price hikes. Management expects full-year 2026 revenue between $1.95B and $2.02B, with EBITDA around $396M, supported by market recovery and regulatory pre-buying. Despite solid performance and fair valuation, risks from geopolitical uncertainty, tariffs, and global trade volatility lead to a cautious Hold rating.

More News

American Eagle Outfitters beats Q2 earnings estimates with strong Aerie brand growth.

American Eagle Outfitters beats Q2 earnings estimates with strong Aerie brand growth.

American Eagle Outfitters reported strong Q2 results with earnings per share of $0.79, far exceeding the $0.22 estimate, and revenue of $1.38 billion, slightly above expectations. The growth was driven by a 25% revenue increase from its Aerie and OFF...

Company Fundamentals
Bullish
2 hours ago
AeroVironment beats EPS expectations but misses revenue estimates amid stock decline.

AeroVironment beats EPS expectations but misses revenue estimates amid stock decline.

AeroVironment reported a strong quarterly earnings per share (EPS) of $0.59, well above analyst expectations of $0.22, showing solid profitability. However, its revenue of $329.06 million fell short of the estimated $451.95 million, reflecting mixed ...

Company Fundamentals
Neutral
3 hours ago
Shopify acquires Tailwind Labs to boost custom storefront and commerce tools for merchants

Shopify acquires Tailwind Labs to boost custom storefront and commerce tools for merchants

Shopify has acquired Tailwind Labs, known for its popular Tailwind CSS framework used by major platforms like ChatGPT and Reddit. The Tailwind team will now focus on helping Shopify merchants design custom storefronts, manage sales and inventory, and...

Company Fundamentals
Bullish
4 hours ago
Insilico Medicine starts Phase III trial for AI-discovered drug Rentosertib to treat idiopathic pulmonary fibrosis.

Insilico Medicine starts Phase III trial for AI-discovered drug Rentosertib to treat idiopathic pulmonary fibrosis.

Insilico Medicine has dosed the first patient in a Phase III clinical trial for Rentosertib, an AI-discovered drug targeting idiopathic pulmonary fibrosis (IPF). The trial, conducted at multiple centers in China, aims to evaluate the drug's efficacy ...

Company Fundamentals
Bullish
4 hours ago
AI-driven data center demand boosts Applied Materials' wafer fab equipment growth to 80% in 2026

AI-driven data center demand boosts Applied Materials' wafer fab equipment growth to 80% in 2026

Applied Materials CEO Gary Dickerson highlighted at the Goldman Sachs conference that AI, especially in data centers, is a major growth driver for the company. The demand for leading-edge wafer fab equipment is surging, with 80% of the growth in 2026...

Market News
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App